{
    "SPADE_UN_19033": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_19033",
            "Peptide Name": "CB-TH j (cecropin B-thanatin peptide hybrid, synthetic AMPs, UCLL1)",
            "Source": "designed,  peptide hybrid",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "RWKIFKKIEKMGGNIRDGIVKAGPRSYCNRRTGKCQRM",
            "Sequence Length": 38,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 4483.33,
            "PI": 11.04,
            "Hydrophobicity": -1.04,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Hongbiao W, Baolong N, Mengkui X, Lihua H, Weifeng S, Zhiqi M. 2005",
                    "Reference": "J Pept Res. 2005 Dec;66(6):382-6. doi: 10.1111/j.1399-3011.2005.00299.x.PubMed",
                    "Title": "Biological activities of cecropin B-thanatin hybrid peptides."
                }
            ],
            "Frequent Amino Acids": "KRG",
            "Absent Amino Acids": "HLOU",
            "Basic Residues": 12,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 12,
            "Polar Residues": 22,
            "Positive Residues": 12,
            "Negative Residues": 2,
            "Net Charge": 10,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (68.42%) toCE-TH gActivity: this construct is antimicrobial since it inhibited the growth of the E. coli expression host by ~50%. Warning: other bacteria not tested.Recombinant production:bacteria:Escherichia coli: expressed and active.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_10162",
                    "Similarity": 1.0,
                    "Sequence": "RWKIFKKIEKMGGSYCNRRTGKCQRM"
                },
                {
                    "SPADE_ID": "SPADE_UN_19029",
                    "Similarity": 1.0,
                    "Sequence": "RWKIFKKIEKMGGNIRDGIVKAGPRSYPVPIIYCNRRTGKCQRM"
                },
                {
                    "SPADE_ID": "SPADE_UN_29112",
                    "Similarity": 1.0,
                    "Sequence": "RWKIFKKIEKMGGSYCNRRTGKCQRM"
                }
            ]
        }
    }
}